{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:25:07Z","timestamp":1793939107569,"version":"4.8.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"8111","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,4,23]]},"DOI":"10.1038\/s41586-025-10005-1","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:03:10Z","timestamp":1770220990000},"page":"1004-1015","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["ZFTA\u2013RELA ependymomas make itaconate to epigenetically drive fusion expression"],"prefix":"10.1038","volume":"652","author":[{"given":"Siva Kumar","family":"Natarajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Haggerty","family":"Skeans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minal","family":"Nenwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjana","family":"Eyunni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateus","family":"Mota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7995-5584","authenticated-orcid":false,"given":"Jill M.","family":"Bayliss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Deogharkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin Taya","family":"Hamanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Pun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan R.","family":"Sweha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1385-6316","authenticated-orcid":false,"given":"Simon","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5393-530X","authenticated-orcid":false,"given":"Eleanor","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rijul","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4032-3619","authenticated-orcid":false,"given":"Olamide","family":"Animasahun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushanth","family":"Sunil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Parolia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8556-7481","authenticated-orcid":false,"given":"Peter","family":"Sajjakulnukit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Panwalkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1460-5464","authenticated-orcid":false,"given":"Madison","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Hawes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8040-6312","authenticated-orcid":false,"given":"Fusheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarita","family":"Santi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Judkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelena","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vigil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5361-7683","authenticated-orcid":false,"given":"Andrea","family":"Franson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Griesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3792-7120","authenticated-orcid":false,"given":"Eric C.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas K.","family":"Foreman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3967-0816","authenticated-orcid":false,"given":"Kulandaimanuvel Antony","family":"Michealraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Agnihotri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7009-3466","authenticated-orcid":false,"given":"Michael","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7539-9472","authenticated-orcid":false,"given":"Richard J.","family":"Gilbertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Koschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9282-3415","authenticated-orcid":false,"given":"Arul M.","family":"Chinnaiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9309-6141","authenticated-orcid":false,"given":"Costas A.","family":"Lyssiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8999-2282","authenticated-orcid":false,"given":"Deepak","family":"Nagrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriram","family":"Venneti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"10005_CR1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature13109","volume":"506","author":"M Parker","year":"2014","unstructured":"Parker, M. et al. C11orf95\u2013RELA fusions drive oncogenic NF-\u03baB signalling in ependymoma. Nature 506, 451\u2013455 (2014).","journal-title":"Nature"},{"key":"10005_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41577-019-0128-5","volume":"19","author":"LAJ O\u2019Neill","year":"2019","unstructured":"O\u2019Neill, L. A. J. & Artyomov, M. N. Itaconate: the poster child of metabolic reprogramming in macrophage function. Nat. Rev. Immunol. 19, 273\u2013281 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"10005_CR3","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","volume":"27","author":"KW Pajtler","year":"2015","unstructured":"Pajtler, K. W. et al. Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 27, 728\u2013743 (2015).","journal-title":"Cancer Cell"},{"key":"10005_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41568-021-00433-2","volume":"22","author":"AH Saleh","year":"2022","unstructured":"Saleh, A. H. et al. The biology of ependymomas and emerging novel therapies. Nat. Rev. Cancer 22, 208\u2013222 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"10005_CR5","first-page":"629","volume":"16","author":"TE Merchant","year":"2002","unstructured":"Merchant, T. E. Current management of childhood ependymoma. Oncology 16, 629\u2013642 (2002).","journal-title":"Oncology"},{"key":"10005_CR6","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1158\/2159-8290.CD-20-0963","volume":"11","author":"T Zheng","year":"2021","unstructured":"Zheng, T. et al. Cross-species genomics reveals oncogenic dependencies in ZFTA\/C11orf95 fusion\u2013positive supratentorial ependymomas. Cancer Discov. 11, 2230\u20132247 (2021).","journal-title":"Cancer Discov."},{"key":"10005_CR7","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol.\u00a023, 1231\u20131251 (2021).","journal-title":"Neuro Oncol."},{"key":"10005_CR8","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/neuonc\/noy118","volume":"20","author":"H Witt","year":"2018","unstructured":"Witt, H. et al. DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment. Neuro Oncol.\u00a020, 1616\u20131624 (2018).","journal-title":"Neuro Oncol."},{"key":"10005_CR9","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1093\/neuonc\/noz069","volume":"21","author":"SA Upadhyaya","year":"2019","unstructured":"Upadhyaya, S. A. et al. Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial. Neuro Oncol.\u00a021, 1319\u20131330 (2019).","journal-title":"Neuro Oncol."},{"key":"10005_CR10","doi-asserted-by":"crossref","unstructured":"Kupp, R. et al. ZFTA-translocations constitute ependymoma chromatin remodeling and transcription factors. Cancer Discov. 11, 2216\u20132229 (2021).","DOI":"10.1158\/2159-8290.CD-20-1052"},{"key":"10005_CR11","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1158\/2159-8290.CD-20-1066","volume":"11","author":"A Arabzade","year":"2021","unstructured":"Arabzade, A. et al. ZFTA\u2013RELA dictates oncogenic transcriptional programs to drive aggressive supratentorial ependymoma. Cancer Discov. 11, 2200\u20132215 (2021).","journal-title":"Cancer Discov"},{"key":"10005_CR12","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1016\/j.celrep.2018.04.099","volume":"23","author":"T Ozawa","year":"2018","unstructured":"Ozawa, T. et al. A de novo mouse model of C11orf95\u2013RELA fusion-driven ependymoma identifies driver functions in addition to NF-\u03baB. Cell Rep. 23, 3787\u20133797 (2018).","journal-title":"Cell Rep."},{"key":"10005_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38044-0","volume":"14","author":"K Okonechnikov","year":"2023","unstructured":"Okonechnikov, K. et al. 3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma. Nat. Commun. 14, 2300 (2023).","journal-title":"Nat. Commun."},{"key":"10005_CR14","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00401-020-02225-8","volume":"140","author":"JJ Zhu","year":"2020","unstructured":"Zhu, J. J. C11orf95\u2013RELA reprograms 3D epigenome in supratentorial ependymoma. Acta Neuropathol. 140, 951\u2013960 (2020).","journal-title":"Acta Neuropathol."},{"key":"10005_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert, B., Solmonson, A. & DeBerardinis, R. J. Metabolic reprogramming and cancer progression. Science 368, eaaw5473 (2020).","journal-title":"Science"},{"key":"10005_CR16","doi-asserted-by":"crossref","unstructured":"Venneti, S. & Thompson, C. B. Metabolic reprogramming in brain tumors. Annu. Rev. Pathol. 12, 515\u2013545 (2017).","DOI":"10.1146\/annurev-pathol-012615-044329"},{"key":"10005_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature10866","volume":"483","author":"S Turcan","year":"2012","unstructured":"Turcan, S. et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483, 479\u2013483 (2012).","journal-title":"Nature"},{"key":"10005_CR18","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1158\/2159-8290.CD-13-0092","volume":"3","author":"JK Killian","year":"2013","unstructured":"Killian, J. K. et al. Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov. 3, 648\u2013657 (2013).","journal-title":"Cancer Discov."},{"key":"10005_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41588-017-0001-z","volume":"50","author":"S Turcan","year":"2018","unstructured":"Turcan, S. et al. Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence. Nat. Genet. 50, 62\u201372 (2018).","journal-title":"Nat. Genet."},{"key":"10005_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature16490","volume":"529","author":"WA Flavahan","year":"2016","unstructured":"Flavahan, W. A. et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529, 110\u2013114 (2016).","journal-title":"Nature"},{"key":"10005_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ccell.2016.05.018","volume":"30","author":"S Inoue","year":"2016","unstructured":"Inoue, S. et al. Mutant IDH1 downregulates ATM and alters dna repair and sensitivity to DNA damage independent of TET2. Cancer Cell 30, 337\u2013348 (2016).","journal-title":"Cancer Cell"},{"key":"10005_CR22","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.it.2019.05.007","volume":"40","author":"A Hooftman","year":"2019","unstructured":"Hooftman, A. & O\u2019Neill, L. A. J. The immunomodulatory potential of the metabolite itaconate. Trends Immunol. 40, 687\u2013698 (2019).","journal-title":"Trends Immunol."},{"key":"10005_CR23","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s42255-022-00676-9","volume":"4","author":"H Zhao","year":"2022","unstructured":"Zhao, H. et al. Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth. Nat. Metab. 4, 1660\u20131673 (2022).","journal-title":"Nat. Metab."},{"key":"10005_CR24","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1021\/acs.jproteome.8b00139","volume":"17","author":"e van quickelberghe","year":"2018","unstructured":"van quickelberghe, e. et al. Identification of immune-responsive gene 1 (IRG1) as a target of A20. J. Proteome Res. 17, 2182\u20132191 (2018).","journal-title":"J. Proteome Res."},{"key":"10005_CR25","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1084\/jem.20180118","volume":"215","author":"S Nair","year":"2018","unstructured":"Nair, S. et al. Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection. J. Exp. Med. 215, 1035\u20131045 (2018).","journal-title":"J. Exp. Med."},{"key":"10005_CR26","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s42255-022-00577-x","volume":"4","author":"F Chen","year":"2022","unstructured":"Chen, F. et al. Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism. Nat. Metab. 4, 534\u2013546 (2022).","journal-title":"Nat. Metab."},{"key":"10005_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36594-x","volume":"14","author":"K Aso","year":"2023","unstructured":"Aso, K. et al. Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming. Nat. Commun. 14, 984 (2023).","journal-title":"Nat. Commun."},{"key":"10005_CR28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cmet.2016.06.004","volume":"24","author":"V Lampropoulou","year":"2016","unstructured":"Lampropoulou, V. et al. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab. 24, 158\u2013166 (2016).","journal-title":"Cell Metab"},{"key":"10005_CR29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41556-022-00853-8","volume":"24","author":"LL Chen","year":"2022","unstructured":"Chen, L. L. et al. Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses. Nat. Cell Biol. 24, 353\u2013363 (2022).","journal-title":"Nat. Cell Biol."},{"key":"10005_CR30","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1158\/2159-8290.CD-22-0825","volume":"13","author":"K Gunn","year":"2023","unstructured":"Gunn, K. et al. (R)-2-Hydroxyglutarate inhibits KDM5 histone lysine demethylases to drive transformation in IDH-mutant cancers. Cancer Discov. 13, 1478\u20131497 (2023).","journal-title":"Cancer Discov."},{"key":"10005_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","volume":"19","author":"W Xu","year":"2011","unstructured":"Xu, W. et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases. Cancer Cell 19, 17\u201330 (2011).","journal-title":"Cancer Cell"},{"key":"10005_CR32","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature11323","volume":"488","author":"M Sasaki","year":"2012","unstructured":"Sasaki, M. et al. IDH1R132H mutation increases murine haematopoietic progenitors and alters epigenetics. Nature 488, 656\u2013659 (2012).","journal-title":"Nature"},{"key":"10005_CR33","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.cmet.2015.06.023","volume":"22","author":"AM Intlekofer","year":"2015","unstructured":"Intlekofer, A. M. et al. Hypoxia induces production of l-2-hydroxyglutarate. Cell Metab. 22, 304\u2013311 (2015).","journal-title":"Cell Metab."},{"key":"10005_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05526-y","volume":"12","author":"V Herranz-P\u00e9rez","year":"2022","unstructured":"Herranz-P\u00e9rez, V. et al. Ependymoma associated protein Zfta is expressed in immature ependymal cells but is not essential for ependymal development in mice. Sci. Rep. 12, 1493 (2022).","journal-title":"Sci. Rep."},{"key":"10005_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40478-021-01135-4","volume":"9","author":"T Ozawa","year":"2021","unstructured":"Ozawa, T. et al. C11orf95\u2013RELA fusion drives aberrant gene expression through the unique epigenetic regulation for ependymoma formation. Acta Neuropathol. Commun. 9, 36 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"10005_CR36","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s13238-014-0078-4","volume":"5","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. The PHD1 finger of KDM5B recognizes unmodified H3K4 during the demethylation of histone H3K4me2\/3 by KDM5B. Protein Cell 5, 837\u2013850 (2014).","journal-title":"Protein Cell"},{"key":"10005_CR37","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nchembio.2087","volume":"12","author":"C Johansson","year":"2016","unstructured":"Johansson, C. et al. Structural analysis of human KDM5B guides histone demethylase inhibitor development. Nat. Chem. Biol. 12, 539\u2013545 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"10005_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40573-y","volume":"9","author":"J Dorosz","year":"2019","unstructured":"Dorosz, J. et al. Molecular architecture of the Jumonji C family histone demethylase KDM5B. Sci. Rep. 9, 4019 (2019).","journal-title":"Sci. Rep."},{"key":"10005_CR39","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nsmb.1400","volume":"15","author":"S Tu","year":"2008","unstructured":"Tu, S. et al. The ARID domain of the H3K4 demethylase RBP2 binds to a DNA CCGCCC motif. Nat. Struct. Mol. Biol. 15, 419\u2013421 (2008).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10005_CR40","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.isci.2018.10.029","volume":"9","author":"P Puchalska","year":"2018","unstructured":"Puchalska, P. et al. Isotope tracing untargeted metabolomics reveals macrophage polarization-state-specific metabolic coordination across intracellular compartments. iScience 9, 298\u2013313 (2018).","journal-title":"iScience"},{"key":"10005_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj1431","volume":"10","author":"EH Ma","year":"2024","unstructured":"Ma, E. H. 13C metabolite tracing reveals glutamine and acetate as critical in vivo fuels for CD8 T cells. Sci. Adv. 10, eadj1431 (2024).","journal-title":"Sci. Adv."},{"key":"10005_CR42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev-bioeng-071516-044546","volume":"19","author":"L Yang","year":"2017","unstructured":"Yang, L., Venneti, S. & Nagrath, D. Glutaminolysis: a hallmark of cancer metabolism. Annu. Rev. Biomed. Eng. 19, 163\u2013194 (2017).","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10005_CR43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ccell.2020.06.004","volume":"38","author":"J Gojo","year":"2020","unstructured":"Gojo, J. et al. Single-cell RNA-seq reveals cellular hierarchies and impaired developmental trajectories in pediatric ependymoma. Cancer Cell 38, 44\u201359 (2020).","journal-title":"Cancer Cell"},{"key":"10005_CR44","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.ccell.2018.04.002","volume":"33","author":"M Momcilovic","year":"2018","unstructured":"Momcilovic, M. et al. The GSK3 signaling axis regulates adaptive glutamine metabolism in lung squamous cell carcinoma. Cancer Cell 33, 905\u2013921 (2018).","journal-title":"Cancer Cell"},{"key":"10005_CR45","doi-asserted-by":"publisher","first-page":"18782","DOI":"10.1073\/pnas.0810199105","volume":"105","author":"DR Wise","year":"2008","unstructured":"Wise, D. R. et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl Acad. Sci. USA 105, 18782\u201318787 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10005_CR46","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature07823","volume":"458","author":"P Gao","year":"2009","unstructured":"Gao, P. et al. c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458, 762\u2013765 (2009).","journal-title":"Nature"},{"key":"10005_CR47","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nm.4464","volume":"24","author":"ML Schulte","year":"2018","unstructured":"Schulte, M. L. et al. Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models. Nat. Med. 24, 194\u2013202 (2018).","journal-title":"Nat. Med."},{"key":"10005_CR48","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","volume":"13","author":"MI Gross","year":"2014","unstructured":"Gross, M. I. et al. Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol. Cancer Ther. 13, 890\u2013901 (2014).","journal-title":"Mol. Cancer Ther."},{"key":"10005_CR49","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.tranon.2019.05.013","volume":"12","author":"AR Hanaford","year":"2019","unstructured":"Hanaford, A. R. et al. Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma. Transl. Oncol. 12, 1314\u20131322 (2019).","journal-title":"Transl. Oncol."},{"key":"10005_CR50","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ccell.2020.07.008","volume":"38","author":"C Chung","year":"2020","unstructured":"Chung, C. et al. Integrated metabolic and epigenomic reprograming by H3K27M mutations in diffuse intrinsic pontine gliomas. Cancer Cell 38, 334\u2013349 (2020).","journal-title":"Cancer Cell"},{"key":"10005_CR51","doi-asserted-by":"publisher","first-page":"e921","DOI":"10.1634\/theoncologist.2018-0489","volume":"24","author":"M Benesch","year":"2019","unstructured":"Benesch, M. et al. Newly diagnosed metastatic intracranial ependymoma in children: frequency, molecular characteristics, treatment, and outcome in the prospective HIT series. Oncologist 24, e921\u2013e929 (2019).","journal-title":"Oncologist"},{"key":"10005_CR52","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/pbc.21276","volume":"50","author":"S Zacharoulis","year":"2008","unstructured":"Zacharoulis, S. et al. Metastatic ependymoma: a multi-institutional retrospective analysis of prognostic factors. Pediatr. Blood Cancer 50, 231\u2013235 (2008).","journal-title":"Pediatr. Blood Cancer"},{"key":"10005_CR53","doi-asserted-by":"publisher","first-page":"10894","DOI":"10.1021\/jacs.9b11962","volume":"142","author":"W Qin","year":"2020","unstructured":"Qin, W. et al. Chemoproteomic profiling of itaconation by bioorthogonal probes in inflammatory macrophages. J. Am. Chem. Soc. 142, 10894\u201310898 (2020).","journal-title":"J. Am. Chem. Soc."},{"key":"10005_CR54","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41586-018-0052-z","volume":"556","author":"M Bambouskova","year":"2018","unstructured":"Bambouskova, M. et al. Electrophilic properties of itaconate and derivatives regulate the I\u03baB\u03b6\u2013ATF3 inflammatory axis. Nature 556, 501\u2013504 (2018).","journal-title":"Nature"},{"key":"10005_CR55","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature25986","volume":"556","author":"EL Mills","year":"2018","unstructured":"Mills, E. L. et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 556, 113\u2013117 (2018).","journal-title":"Nature"},{"key":"10005_CR56","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41589-019-0323-5","volume":"15","author":"W Qin","year":"2019","unstructured":"Qin, W. et al. S-glycosylation-based cysteine profiling reveals regulation of glycolysis by itaconate. Nat. Chem. Biol. 15, 983\u2013991 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"10005_CR57","doi-asserted-by":"publisher","first-page":"14274","DOI":"10.1074\/jbc.M115.685792","volume":"291","author":"T Cordes","year":"2016","unstructured":"Cordes, T. et al. Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J. Biol. Chem. 291, 14274\u201314284 (2016).","journal-title":"J. Biol. Chem."},{"key":"10005_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13078-5","volume":"10","author":"ST Liao","year":"2019","unstructured":"Liao, S. T. et al. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects. Nat. Commun. 10, 5091 (2019).","journal-title":"Nat. Commun."},{"key":"10005_CR59","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41589-018-0217-y","volume":"15","author":"RA Kulkarni","year":"2019","unstructured":"Kulkarni, R. A. et al. A chemoproteomic portrait of the oncometabolite fumarate. Nat. Chem. Biol. 15, 391\u2013400 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"10005_CR60","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nature08617","volume":"462","author":"L Dang","year":"2009","unstructured":"Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739\u2013744 (2009).","journal-title":"Nature"},{"key":"10005_CR61","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s42255-022-00565-1","volume":"4","author":"W He","year":"2022","unstructured":"He, W. et al. Mesaconate is synthesized from itaconate and exerts immunomodulatory effects in macrophages. Nat. Metab. 4, 524\u2013533 (2022).","journal-title":"Nat. Metab."},{"key":"10005_CR62","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/nature09173","volume":"466","author":"RA Johnson","year":"2010","unstructured":"Johnson, R. A. et al. Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 466, 632\u2013636 (2010).","journal-title":"Nature"},{"key":"10005_CR63","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00401-011-0866-3","volume":"122","author":"T Milde","year":"2011","unstructured":"Milde, T. et al. A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat. Acta Neuropathol. 122, 637\u2013650 (2011).","journal-title":"Acta Neuropathol."},{"key":"10005_CR64","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-019-1564-8","volume":"15","author":"HJ Lee","year":"2019","unstructured":"Lee, H. J., Kremer, D. M., Sajjakulnukit, P., Zhang, L. & Lyssiotis, C. A. A large-scale analysis of targeted metabolomics data from heterogeneous biological samples provides insights into metabolite dynamics. Metabolomics 15, 103 (2019).","journal-title":"Metabolomics"},{"key":"10005_CR65","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00401-017-1752-4","volume":"134","author":"P Panwalkar","year":"2017","unstructured":"Panwalkar, P. et al. Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome. Acta Neuropathol. 134, 705\u2013714 (2017).","journal-title":"Acta Neuropathol."},{"key":"10005_CR66","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1038\/s41588-024-01893-6","volume":"56","author":"A Parolia","year":"2024","unstructured":"Parolia, A. et al. NSD2 is a requisite subunit of the AR\/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis. Nat. Genet. 56, 2132\u20132143 (2024).","journal-title":"Nat. Genet."},{"key":"10005_CR67","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"10005_CR68","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"10005_CR69","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab008","volume":"10","author":"P Danecek","year":"2021","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008 (2021).","journal-title":"Gigascience"},{"key":"10005_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP\u2013Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"10005_CR71","doi-asserted-by":"publisher","first-page":"D1082","DOI":"10.1093\/nar\/gkad987","volume":"52","author":"BJ Raney","year":"2024","unstructured":"Raney, B. J. et al. The UCSC Genome Browser database: 2024 update. Nucleic Acids Res. 52, D1082\u2013D1088 (2024).","journal-title":"Nucleic Acids Res."},{"key":"10005_CR72","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/1471-2105-11-237","volume":"11","author":"LJ Zhu","year":"2010","unstructured":"Zhu, L. J. et al. ChIPpeakAnno: a Bioconductor package to annotate ChIP\u2013seq and ChIP\u2013chip data. BMC Bioinformatics 11, 237 (2010).","journal-title":"BMC Bioinformatics"},{"key":"10005_CR73","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu, G., Wang, L. G. & He, Q. Y. ChIP seeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31, 2382\u20132383 (2015).","journal-title":"Bioinformatics"},{"key":"10005_CR74","doi-asserted-by":"publisher","first-page":"W187","DOI":"10.1093\/nar\/gku365","volume":"42","author":"F Ram\u00edrez","year":"2014","unstructured":"Ram\u00edrez, F., D\u00fcndar, F., Diehl, S., Gr\u00fcning, B. A. & Manke, T. DeepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res. 42, W187\u2013W191 (2014).","journal-title":"Nucleic Acids Res."},{"key":"10005_CR75","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213\u20131218 (2013).","journal-title":"Nat. Methods"},{"key":"10005_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"10005_CR77","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-10005-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-10005-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-10005-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:03:12Z","timestamp":1779375792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-10005-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":77,"journal-issue":{"issue":"8111","published-print":{"date-parts":[[2026,4,23]]}},"alternative-id":["10005"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-10005-1","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"8 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.K.N., J.L. and S.V. are listed as inventors on US provisional patent 63\/919,979. A.M.C. is a co-founder and serves on the Scientific Advisory Board of Lynx Dx, Esanik Therapeutics, Medsyn and Flamingo Therapeutics. A.M.C. is a scientific consultant for EdenRoc, Proteovant, Aurigene Oncology, RAPPTA, Belharra and Tempus. C.A.L. has received consulting fees from Astellas Pharmaceuticals, Odyssey Therapeutics and T-Knife Therapeutics, and is an inventor on patents pertaining to KRAS-regulated metabolic pathways, redox control pathways in pancreatic cancer, and targeting the GOT1 pathway as a therapeutic approach (US patent 2015126580-A1, 05\/07\/2015; US patent 20190136238, 05\/09\/2019; international patent WO2013177426-A2, 04\/23\/2015).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}